Author: Haritha Karyampudi

Driven by a deep passion for healthcare, Haritha is a dedicated medical content writer with a knack for transforming complex concepts into accessible, engaging narratives. With extensive writing experience, she brings a unique blend of expertise and creativity to every piece, empowering readers with valuable insights into the world of medicine.

Predicting Heart Performance Using AI
Predictive Analysis of Heart Performance Using AI

The biggest cause of adult death worldwide is coronary heart disease. The coronary angiography method.

Peanut Patch desensitizing Peanut Allergy
Peanut Patch Desensitized Peanut Allergic Children

A new study involving Children’s Hospital of Philadelphia (CHOP) researchers found that daily use of.

Cervical Cancer Screening
Mailing Testing kits Doubles Cervical Cancer Screening

The UNC Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center found.

French Polynesia nuke test
French Polynesia Nuke Tests Raised Cancer Risk, Study Unveils

According to a study released that used declassified military data for the first time, Polynesians.

Tinea Cases in South Asia
First Cases of Tinea in The U.S. Caused by T. indotineae

Tinea is a common, highly contagious illness of the skin, hair, or nails that is.

Cannabis During Pregnancy
Negative Effects of Cannabis During Pregnancy

As more people use cannabis recreationally, perceptions toward the drug are shifting. According to a.

Therapy Resistant Cancers
Targeting Uncontrolled Inflammation May Help Treat Therapy Resistant Cancers

Scientists at the Van Andel Institute have identified how a certain gene mutation causes an.

Scented Soaps attract Mosquitoes
Research Revealed Scented Soaps Attract Mosquitoes

Humans can smell. Each person has a distinct body odor. For generations, people have used.

Radiation Technique for Cancer Cells
New Radiation Technique From Mitchell Cancer Institute

A new radiation technique, The Elekta Versa HD, a medical linear accelerator that focuses radiation.

Menopause Vasomotor Symptoms
FDA ApprovedĀ Astellas’ VEOZAH for Menopause Vasomotor Symptoms

On May 12, Astellas Pharma Inc announced that the FDA had approved VEOZAHTM (fezolinetant) 45.